ECBS 2020 - BS DOCUMENTS

28 October 2020

WHO/BS/2020.2401 Report on a Collaborative Study for Proposed Candidate 1st International Standard for the biological activities of Trastuzumab WHO/BS/2020.2401 Report on a Collaborative Study for Proposed Candidate 1st International Standard for the biological activities of Trastuzumab

18 November 2020

WHO/BS.2020.2402 Collaborative Study for the Establishment of a WHO International Standard for SARS-CoV-2 RNA WHO/BS.2020.2402 Collaborative Study for the Establishment of a WHO International Standard for SARS-CoV-2 RNA

18 November 2020

WHO/BS.2020.2403 Establishment of the WHO International Standard and Reference Panel for anti-SARS-CoV-2 antibody WHO/BS.2020.2403 Establishment of the WHO International Standard and Reference Panel for anti-SARS-CoV-2 antibody

19 November 2020

WHO/BS:2020.2404 - 1st WHO International Standard for SARS-CoV-2 Antigen WHO/BS:2020.2404 - 1st WHO International Standard for SARS-CoV-2 Antigen

19 August 2020

WHO/BS/2020.2389 Proposed 3rd International Standard for Interferon alpha 2b WHO/BS/2020.2389 Proposed 3rd International Standard for Interferon alpha 2b

19 August 2020

WHO/BS/2020.2390 International collaborative study to evaluate a proposed 1st WHO reference reagent for anti-human platelet antigen-15b (anti-HPA-15b)Code: 18/220 WHO/BS/2020.2390 International collaborative study to evaluate a proposed 1st WHO reference reagent for anti-human platelet antigen-15b (anti-HPA-15b)Code: 18/220

19 August 2020

WHO/BS/2020.2391 WHO International Collaborative Study of the Proposed 1st International Standard for Bevacizumab WHO/BS/2020.2391 WHO International Collaborative Study of the Proposed 1st International Standard for Bevacizumab

19 August 2020

WHO/BS/2020.2392 Collaborative Study to Evaluate the 1st WHO International Standard for Herpes Simplex Virus (HSV) DNA for Nucleic Acid Amplification Technology (NAT)-Based Assays WHO/BS/2020.2392 Collaborative Study to Evaluate the 1st WHO International Standard for Herpes Simplex Virus (HSV) DNA for Nucleic Acid Amplification Technology (NAT)-Based Assays

2 September 2020

WHO/BS/2020.2393 - Proposed 2nd WHO International Standard for insulin-like growth factor-I (IGF-I), recombinant, human WHO/BS/2020.2393 - Proposed 2nd WHO International Standard for insulin-like growth factor-I (IGF-I), recombinant, human

7 September 2020

WHO/BS/2020.2394 - Proposed 1st International Virus Reference Standards for Adventitious Virus Detection in Biological Products by Next-Generation Sequencing (NGS) Technologies (CBER-5) WHO/BS/2020.2394 - Proposed 1st International Virus Reference Standards for Adventitious Virus Detection in Biological Products by Next-Generation Sequencing (NGS) Technologies (CBER-5)

19 August 2020

WHO/BS/2020.2395 Proposed 6th WHO International Standard for human chorionic gonadotrophin WHO/BS/2020.2395 Proposed 6th WHO International Standard for human chorionic gonadotrophin

19 August 2020

WHO/BS/2020.2396 Request to initiate new WHO reference material projects for biologicals WHO/BS/2020.2396 Request to initiate new WHO reference material projects for biologicals

22 September 2020

WHO/BS/2020.2397 1st IS West Nile Virus ECBS 2020 KEMPSTER NIBSC WHO/BS/2020.2397 1st IS West Nile Virus ECBS 2020 KEMPSTER NIBSC

19 August 2020

WHO/BS/2020.2398 Establishment of 1st WHO International Standard for anti-MERS-CoV antibodyGiada WHO/BS/2020.2398 Establishment of 1st WHO International Standard for anti-MERS-CoV antibodyGiada

21 July 2020

WHO/BS/2020.2382 WHO 1st RR for anti-malaria (Plasmodium Vivax) human plasma WHO/BS/2020.2382 WHO 1st RR for anti-malaria (Plasmodium Vivax) human plasma

21 July 2020

WHO/BS/2020.2383 Requests to initiate new WHO reference material projects for biologicals WHO/BS/2020.2383 Requests to initiate new WHO reference material projects for biologicals

21 July 2020

WHO/BS/2020.2384 WHO 3rd IS for Thrombin WHO/BS/2020.2384 WHO 3rd IS for Thrombin

21 July 2020

WHO/BS/2020.2385 WHO 1st IS for Plasmodium Vivax antigens WHO/BS/2020.2385 WHO 1st IS for Plasmodium Vivax antigens